Search
for
Sort by
Research 871–900 of 1000+
- Rapidly progressive alopecia areata totalis in a COVID‐19 patient, unresponsive to tofacitinib
- The AndroCoV Clinical Scoring for COVID-19 Diagnosis: A Prompt, Feasible, Costless, and Highly Sensitive Diagnostic Tool for COVID-19 Based on a 1757-Patient Cohort
- Saying no to SARS-CoV-2: the potential of nitric oxide in the treatment of COVID-19 pneumonia
- Hormone Therapy in the Era of the COVID-19 Pandemic: A Review
- A systematic review of dermatologic manifestations among adult patients with COVID‐19 diagnosis
- Molecular Mechanisms Lead to Sex-Specific COVID-19 Prognosis and Targeted Therapies
- Sociodemographic predictors of outcomes in COVID-19: examining the impact of ethnic disparities in Northern Nevada
- Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19
- “MATH+” Multi-Modal Hospital Treatment Protocol for COVID-19 Infection: Clinical and Scientific Rationale
- Skin disorders associated with the COVID‐19 pandemic: A review
- Sociodemographic Predictors of Outcomes in COVID-19: Examining the Impact of Ethnic Disparities in Northern Nevada
- New insights into alopecia areata during COVID‐19 pandemic: When infection or vaccination could play a role
- Consumer attitudes toward aging skin during the COVID-19 pandemic
- ACE1 rs1799752 polymorphism is not associated with long-COVID symptomatology in previously hospitalized COVID-19 survivors
- Role of ACE2 polymorphism in COVID-19: impact of age
- The Pathological Culprit of Neuropathic Skin Pain in Long COVID-19 Patients: A Case Series
- Hair and nail manifestations of COVID‐19
- Contrasting Narratives of Race and Fatness in Covid-19
- Proxalutamide Improves Inflammatory, Immunologic, and Thrombogenic Markers in Mild-to-Moderate COVID-19 Males and Females: an Exploratory Analysis of a Randomized, Double-Blinded, Placebo-Controlled Trial Early Antiandrogen Therapy (EAT) with Proxalutamide (The EAT-Proxa Biochemical AndroCoV-Trial)
- Proxalutamide Reduction of Mortality Rate in Hospitalized COVID-19 Patients Depends on Treatment Duration – an Exploratory Analysis of the Proxa-Rescue AndroCoV Trial
- Clinical course of alopecia after COVID-19
- Rare and common manifestations of COVID‐19 in children
- Association between Mesenchymal Stem Cells and COVID-19 Therapy: Systematic Review and Current Trends
- Androgenetic alopecia in women and men is not related to COVID‐19 infection severity: a prospective cohort study of hospitalized COVID‐19 patients
- Gender/sex, race/ethnicity, similarities/differences among SARS-CoV, MERS-CoV, and COVID-19 patients
- Analysing the patient experience of COVID‐19: Exploring patients' experiences of hospitalisation and their quality of life post discharge
- New‐onset and exacerbated skin diseases after COVID‐19 infection: A systematic review
- Correlation Between Nongenomic Action of C19-Steroids and COVID-19 Severity
- Androgens and Antiandrogens influence on COVID-19 disease in men
- A window into the vascular endothelium in COVID-19: Nails